Skip to content

Clinical trials

Epilepsies, Partial trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Partial Country / region: Belgium Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20052
20063
20071
20082
20121
20152
20181
20191
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Enrolling by invitation2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma3
Bial - Portela C S.A.2
Biohaven Therapeutics Ltd.2
Pfizer2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
Cyberonics, Inc.1
GlaxoSmithKline1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
LivaNova1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Partial20
Epilepsy13
Seizures7
Drug Resistant Epilepsy3
Epilepsy, Complex Partial1
Epilepsy, Tonic-Clonic1

Trials

Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.